News
Resources
Blog
Sites
COVID-19 Response: Supporting the frontline
By Stephen J. Ubl | March 30, 2020
Updated 7/13/2020 In these unprecedented times, America’s biopharmaceutical companies are coming together to achieve one shared goal: to combat COVID-19, a disease caused by a novel strain of...
Read More
America’s biopharmaceutical companies are working around the clock to beat coronavirus
By Holly Campbell | March 20, 2020
Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) underscored the industry’s commitment to finding solutions to prevent,...
Read More
ICYMI: America’s biopharmaceutical companies are taking on COVID-19
By Andrew Powaleny | March 16, 2020
The biopharmaceutical industry is taking on COVID-19, a disease caused by a novel strain of coronavirus, through research and development (R&D) into prevention and treatment, in-kind financial...
Read More
R&D Focus: New report shows nearly 600 medicines in development for pediatric patients
By Andrew Powaleny | February 13, 2020
America’s biopharmaceutical researchers are committed to studying, developing and testing medicines to meet the unique needs of pediatric patients. New treatment options for infants, children and...
Read More
Clinical Trials Awareness Week: Celebrating innovation in clinical research
By Richard Moscicki, M.D. | May 15, 2019
This week is Clinical Trials Awareness Week — an annual event to recognize the important role clinical trials play in helping develop safe and effective medicines.
Read More
Clinical trials impact state economies
By John Corea | May 3, 2019
A new report from TEConomy Partners, supported by PhRMA, provides estimates of industry-sponsored clinical trial activity in each of the 50 states, including the number of trials active, the...
Read More
Examining the truth behind clinical trial costs
By John Corea | October 2, 2018
Last week, a study appearing in the Journal of the American Medical Association (JAMA) Internal Medicine, evaluated the costs specifically associated with successful clinical trials for novel...
Read More
New report details the setbacks and challenges to Alzheimer’s research
By Gretta Stone | September 12, 2018
Illustrating the challenges of developing medicines to fight Alzheimer’s disease, a new analysis found that between 1998 and 2017, there were 146 unsuccessful medicines in clinical trials for...
Read More
Guest post: Ensuring communities have a seat at the table: The importance of diversity in clinical trials
By Guest Contributor | May 25, 2018
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Bringing innovation to clinical trial design
By Richard Moscicki, M.D. | April 23, 2018
Clinical trials are critical to the discovery and development of innovative medicines that enable patients to live longer, healthier lives. As the biopharmaceutical industry works to identify,...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
